Two oral presentations and nine poster presentations will highlight exciting progress in AskBio’s clinical and pre-clinical ...

Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”) a clinical-stage biopharmaceutical company ...

The14th Binniel Lake Conference held here in the campus town of Moodabidire ended on Sunday with a call to sensitise GenX ...

Poster presentations include data supporting QTORIN™ rapamycin 3.9% anhydrous gel as a potential targeted therapy for the ...

Podium on AI Simulation Recognized as 'Top 5 Applied Research' at This Year's Congress AI-Powered Skin Diagnostic System and ...

Communicating research through presentations and publications is an important part of the research process ... Several undergraduate research programs and academic units also have symposiums/poster ...

Two oral presentations and nine poster presentations will highlight exciting progress in AskBio's clinical and pre-clinical pipeline and ...

SEATTLE, Oct. 04, 2024 (GLOBE NEWSWIRE) -- (OTC Pink: KANT) , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune ...

IANCON-2024 features lectures, paper sessions, symposiums, and workshops on various neurology topics by experts worldwide.

Arbutus Biopharma Corporation (Nasdaq: ABUS) is poised to present significant findings on imdusiran, its RNAi therapeutic, ...

The NIMS Sushma Innovation and Incubation Center (NSIIC) proudly hosted its annual Innovation Day on October 15, 2024, at NIMS University. This event provided a dynamic platform for students, faculty, ...